ConductScience.org, home

Paper39998677

CDX2 and SATB2 loss are associated with myeloid cell infiltration and poor survival in colorectal cancer.

Sirniö P and 19 others. Cancer Immunol Immunother, 2025. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. CDX2 and SATB2 loss are associated with myeloid cell infiltration and poor survival in colorectal cancer. Papers, record 39998677. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39998677

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
CDX2 and SATB2 loss are associated with myeloid cell infiltration and poor survival in colorectal cancer.
PubMed
Journal
Cancer Immunol Immunother
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2025-05-10
PubMed

Authors20

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sirniö PPäivi
2Elomaa HHanna
3Tuomisto AAnne
4Äijälä VKVille K
5Karjalainen HHenna
6Kastinen MMeeri
7Tapiainen VVVilja V
8Sirkiä OOnni
9Ahtiainen MMaarit
10Helminen OOlli
11Wirta EVErkki-Ville
12Rintala JJukka
13Meriläinen SSanna
14Saarnio JJuha
15Rautio TTero
16Seppälä TTToni T
17Böhm JJan
18Mecklin JPJukka-Pekka
19Mäkinen MJMarkus J
20Väyrynen JPJuha Phttps://orcid.org/0000-0002-8683-2996

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Colorectal NeoplasmsMajor topic
Matrix Attachment Region Binding ProteinsMajor topic
CDX2 Transcription FactorMajor topic
Transcription FactorsMajor topic
Myeloid CellsMajor topic
Humans
Male
Female
Prognosis
Middle Aged
Aged
Tumor Microenvironment
Biomarkers, Tumor
Adult

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
59-5619SyöpäsäätiöPubMed
220257PEmil Aaltosen SäätiöPubMed
6021Suomen Lääketieteen SäätiöPubMed
230229Sigrid Juséliuksen SäätiöPubMed

Source PubMed

Download CSV of grants

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125126956The clinical perspectives of CDX2 expression in colorectal cancer: a qualitative systematic review.Surg Oncol2014https://conductscience.org/library/papers/25126956PubMed
237002343Spatially resolved multimarker evaluation of CD274 (PD-L1)/PDCD1 (PD-1) immune checkpoint expression and macrophage polarisation in colorectal cancer.Br J Cancer2023https://conductscience.org/library/papers/37002343PubMed
338369188Quantitative Multiplexed Analysis of Indoleamine 2,3-Dioxygenase (IDO) and Arginase-1 (ARG1) Expression and Myeloid Cell Infiltration in Colorectal Cancer.Mod Pathol2024https://conductscience.org/library/papers/38369188PubMed
433894556Immunohistochemical expression and significance of SATB2 protein in colorectal cancer.Ann Diagn Pathol2021https://conductscience.org/library/papers/33894556PubMed
532737450Mismatch repair phenotype determines the implications of tumor grade and CDX2 expression in stage II-III colon cancer.Mod Pathol2021https://conductscience.org/library/papers/32737450PubMed
631121192CDX2 and Muc2 immunohistochemistry as prognostic markers in stage II colon cancer.Hum Pathol2019https://conductscience.org/library/papers/31121192PubMed
734582804SATB2 preserves colon stem cell identity and mediates ileum-colon conversion via enhancer remodeling.Cell Stem Cell2022https://conductscience.org/library/papers/34582804PubMed
822326557TNF-α-induced down-regulation of CDX2 suppresses MEP1A expression in colitis.Biochim Biophys Acta2012https://conductscience.org/library/papers/22326557PubMed
935449453Prognostic significance of spatial and density analysis of T lymphocytes in colorectal cancer.Br J Cancer2022https://conductscience.org/library/papers/35449453PubMed
1030001238Loss of SATB2 Expression in Colorectal Carcinoma Is Associated With DNA Mismatch Repair Protein Deficiency and BRAF Mutation.Am J Surg Pathol2018https://conductscience.org/library/papers/30001238PubMed
1124713733The role of SATB2 as a diagnostic marker for tumors of colorectal origin: Results of a pathology-based clinical prospective study.Am J Clin Pathol2014https://conductscience.org/library/papers/24713733PubMed
1229675807The prognostic impact of CDX2 correlates with the underlying mismatch repair status and BRAF mutational status but not with distant metastasis in colorectal cancer.Virchows Arch2018https://conductscience.org/library/papers/29675807PubMed
1326789870CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.N Engl J Med2016https://conductscience.org/library/papers/26789870PubMed
1429439001The Cdx2 homeobox gene suppresses intestinal tumorigenesis through non-cell-autonomous mechanisms.J Exp Med2018https://conductscience.org/library/papers/29439001PubMed
1525663765Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients.World J Gastroenterol2015https://conductscience.org/library/papers/25663765PubMed
1631869737The local inflammatory response in colorectal cancer - Type, location or density? A systematic review and meta-analysis.Cancer Treat Rev2020https://conductscience.org/library/papers/31869737PubMed
1736819801Diagnostic accuracy of SATB2 in identifying primary and metastatic colorectal carcinoma: a comparative immunohistochemical study.Ecancermedicalscience2022https://conductscience.org/library/papers/36819801PubMed
1835985421The transcription factor Cdx2 regulates inflammasome activity through expression of the NLRP3 suppressor TRIM31 to maintain intestinal homeostasis.J Biol Chem2022https://conductscience.org/library/papers/35985421PubMed
1937325467Potential predictors for CDX2 expression loss and mismatch repair deficiency in colorectal cancer.Pathol Oncol Res2023https://conductscience.org/library/papers/37325467PubMed
2017008531Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.Science2006https://conductscience.org/library/papers/17008531PubMed

See all 45 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn Papers
42027640Role of CDX2 in the prognosis of colorectal cancer across stages 0-IV.Oncol Lett2026https://conductscience.org/library/papers/42027640

Source PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CDX21045PubTator's text mininghttps://conductscience.org/library/genes/1045NCBI Gene
SATB223314PubTator's text mininghttps://conductscience.org/library/genes/23314NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39998677

GET https://conductscience.org/api/papers/v1/39998677/references?page=2